Hedge fund profile
Wellington Biotechnology Long/short Fund (bermuda) L.P.
Wellington Biotechnology Long/short Fund (bermuda) L.P. is reported as a hedge fund in Form ADV private-fund disclosures. The adviser is Wellington Alternative Investments, based in Boston, Massachusetts, United States.
$166.0Mgross assets
$2.0Mminimum
13owners
3(c)(7)exemption
Disclosure fields
Fund facts
SEC private fund ID805-7286263013
Reference ID171284
JurisdictionBermuda
Fund of fundsNo
Master fundYes
Feeder fundNo
Non-US ownership99%
Assets valued100%
Annual auditYes
GAAPYes
Source periodMarch 2026
Date submitted03/31/2026 07:08:57 PM
Adviser
Wellington Alternative Investments
TypeRegistered investment adviser
SEC number801-107461
CRD226715
Regulatory AUM$92.2B
Compliance signals
Exempt from registration Sales limitation not marked Prime brokers reported Custodians reported
Service providers
Reported counterparties
General partners
Wellington Alternative Investments LLC
Auditors
PRICEWATERHOUSECOOPERS LLP
Prime brokers
GOLDMAN SACHS & CO. LLCBOFA SECURITIES, INC.MORGAN STANLEY & CO. LLCJ.P. MORGAN SECURITIES LLC
Custodians
J.P. MORGAN SECURITIES LLCMORGAN STANLEY & CO. LLCGOLDMAN SACHS & CO. LLCSTATE STREET BANK AND TRUST COMPANYBOFA SECURITIES, INC.
Administrators
INTERNATIONAL FUND SERVICES (N.A.), L.L.C.
Marketers
WELLINGTON FUNDS DISTRIBUTORS INC.ICAPITAL GLOBAL ALTERNATIVES, LLC
Same adviser